Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An observational study of Macuneos in mild dry age related macular degeneration

Trial Profile

An observational study of Macuneos in mild dry age related macular degeneration

Planning
Phase of Trial: Phase II

Latest Information Update: 02 Jul 2018

At a glance

  • Drugs Macuneos (Primary)
  • Indications Dry age-related macular degeneration
  • Focus Therapeutic Use
  • Acronyms MACA-OBS
  • Most Recent Events

    • 02 Jul 2018 According to a Biophytis media release, this study will be initiated in second half of 2018.
    • 22 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top